{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:44:16Z","timestamp":1791229456023,"version":"4.1.0"},"reference-count":90,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>In recent years, scientific interest in the use of the ketogenic diet (KD) as a complementary approach to the standard cancer therapy has grown, in particular against those of the central nervous system (CNS). In metabolic terms, there are the following differences between healthy and neoplastic cells: neoplastic cells divert their metabolism to anaerobic glycolysis (Warburg effect), they alter the normal mitochondrial functioning, and they use mainly certain amino acids for their own metabolic needs, to gain an advantage over healthy cells and to lead to a pro-oncogenetic effect. Several works in literature speculate which are the molecular targets of KD used against cancer. The following different mechanisms of action will be explored in this review: metabolic, inflammatory, oncogenic and oncosuppressive, ROS, and epigenetic modulation. Preclinical and clinical studies on the use of KD in CNS tumors have also increased in recent years. An interesting hypothesis emerged from the studies about the possible use of a ketogenic diet as a combination therapy along with chemotherapy (CT) and radiotherapy (RT) for the treatment of cancer. Currently, however, clinical data are still very limited but encouraging, so we need further studies to definitively validate or disprove the role of KD in fighting against cancer.<\/jats:p>","DOI":"10.3390\/nu14183851","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T04:49:22Z","timestamp":1663562962000},"page":"3851","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Ketogenic Diet in the Treatment of Gliomas and Glioblastomas"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2062-2547","authenticated-orcid":false,"given":"Simone","family":"Dal Bello","sequence":"first","affiliation":[{"name":"Clinical Neurology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy"},{"name":"Department of Medical Area, University of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Valdemarin","sequence":"additional","affiliation":[{"name":"Clinical Neurology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy"},{"name":"Department of Medical Area, University of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Martinuzzi","sequence":"additional","affiliation":[{"name":"Department of Medical Area, University of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Filippi","sequence":"additional","affiliation":[{"name":"Clinical Neurology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy"},{"name":"Department of Medical Area, University of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Gigli","sequence":"additional","affiliation":[{"name":"Clinical Neurology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy"},{"name":"Department of Medical Area, University of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Valente","sequence":"additional","affiliation":[{"name":"Clinical Neurology Unit, Santa Maria della Misericordia University Hospital, 33100 Udine, Italy"},{"name":"Department of Medical Area, University of Udine, 33100 Udine, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11910-021-01152-9","article-title":"Epidemiology of Brain and Other CNS Tumors","volume":"21","author":"Ostrom","year":"2021","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Debinski, W. (2021). Gliomas, Exon publications.","DOI":"10.36255\/exonpublications.gliomas.2021"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sarga\u00e7o, B., Oliveira, P.A., Antunes, M.L., and Moreira, A.C. (2022). Effects of the Ketogenic Diet in the Treatment of Gliomas: A Systematic Review. Nutrients, 14.","DOI":"10.3390\/nu14051007"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1474-4422(04)00807-5","article-title":"More fat and fewer seizures: Dietary therapies for epilepsy","volume":"3","author":"Kossoff","year":"2004","journal-title":"Lancet Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s13311-018-0666-8","article-title":"Ketogenic Diets for adult Neurological Disorders","volume":"15","author":"McDonald","year":"2018","journal-title":"Neurotherapeutics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biocel.2015.01.022","article-title":"Mitochondria: The ketogenic diet\u2014A metabolism-based therapy","volume":"63","author":"Vidali","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Valente, M., Garbo, R., Filippi, F., Antonutti, A., Ceccarini, V., Tereshko, Y., Di Lorenzo, C., and Gigli, G.L. (2022). Migraine Prevention through Ketogenic Diet: More than Body Mass Composition Changes. J. Clin. Med. Artic., 11.","DOI":"10.3390\/jcm11174946"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Di Lorenzo, C., Ballerini, G., Barbanti, P., Bernardini, A., D\u2019Arrigo, G., Egeo, G., Frediani, F., Garbo, R., Pierangeli, G., and Prudenzano, M.P. (2021). Applications of ketogenic diets in patients with headache: Clinical recommendations. Nutrients, 13.","DOI":"10.20944\/preprints202104.0794.v1"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Longo, R., Peri, C., Cricr\u00ec, D., Coppi, L., Caruso, D., Mitro, N., De Fabiani, E., and Crestani, M. (2019). Ketogenic diet: A new light shining on old but gold biochemistry. Nutrients, 11.","DOI":"10.3390\/nu11102497"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"D\u0105bek, A., Wojtala, M., Pirola, L., and Balcerczyk, A. (2020). Modulation of Cellular Biochemistry, Epigenetics and Metabolomics by Ketone Bodies. Implications of the Ketogenic Diet in the Physiology of the Organism and Pathological States. Nutrients, 12.","DOI":"10.3390\/nu12030788"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Grabacka, M., Pierzchalska, M., Dean, M., and Reiss, K. (2016). Regulation of ketone body metabolism and the role of PPAR\u03b1. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17122093"},{"key":"ref_12","unstructured":"Kossoff, B., Turnern, W., Doerrer, Z., Cervenka, S., and Henry, M. (2016). The Ketogenic and Modified Atkins Diet Treatments for Epilepsy and Other Disorders, Springer. [6th ed.]."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s40618-019-01061-2","article-title":"Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: Systematic review and consensus statement from the Italian Society of Endocrinology (SIE)","volume":"42","author":"Caprio","year":"2019","journal-title":"J. Endocrinol. Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.redox.2017.04.018","article-title":"Teaching the basics of cancer metabolism: Developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism","volume":"12","author":"Kalyanaraman","year":"2017","journal-title":"Redox Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg Effect: How Does it Benefit Cancer Cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumours in the body","volume":"8","author":"Warburg","year":"1926","journal-title":"J. Gen. Physiol."},{"key":"ref_17","unstructured":"Nelson, D.L., and Cox, M.M. (2008). Lehninger Principles of Biochemistry, W. H. Freeman and Company. [5th ed.]."},{"key":"ref_18","unstructured":"Nelson, D.L., and Cox, M.M. (2010). I Principi di Biochimica di Lehninger, Zanichelli editore S.p.A.. [5th ed.]."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Bott, A.J., Maimouni, S., and Zong, W.-X. (2019). The pleiotropic effects of glutamine metabolism in cancer. Cancers, 11.","DOI":"10.3390\/cancers11060770"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1083\/jcb.201604085","article-title":"The importance of serine metabolism in cancer","volume":"214","author":"Mattaini","year":"2016","journal-title":"J. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"63679","DOI":"10.18632\/oncotarget.11626","article-title":"Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase","volume":"7","author":"Xiao","year":"2016","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"McDonald, T., and Cervenka, M. (2018). The expanding role of Ketogenic diets in adult neurological disorders. Brain Sci., 8.","DOI":"10.3390\/brainsci8080148"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Barrea, L., Caprio, M., Tuccinardi, D., Moriconi, E., Di Renzo, L., Muscogiuri, G., Colao, A., and Savastano, S. (2020). Could ketogenic diet \u2018starve\u2019 cancer?. Emerging evidence., 1\u201322.","DOI":"10.1080\/10408398.2020.1847030"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/ijc.28809","article-title":"Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer","volume":"135","author":"Poff","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2014.01.031","article-title":"PKM2 contributes to cancer metabolism","volume":"356","author":"Wong","year":"2015","journal-title":"Cancer Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","article-title":"Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1","volume":"145","author":"Luo","year":"2011","journal-title":"Cell"},{"key":"ref_27","first-page":"606","article-title":"A ketogenic diet attenuates proliferation and stemness of glioma stem-like cells by altering metabolism resulting in increased ROS production","volume":"56","author":"Ji","year":"2019","journal-title":"Int. J. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Woolf, E.C., Curley, K.L., Liu, Q., Turner, G.H., Charlton, J.A., Preul, M.C., and Scheck, A.C. (2015). The ketogenic diet alters the hypoxic response and affects expression of proteins associated with angiogenesis, invasive potential and vascular permeability in a mouse glioma model. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0130357"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.bcp.2006.06.029","article-title":"Inflammation and cancer: How hot is the link?","volume":"72","author":"Aggarwal","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.plefa.2003.09.008","article-title":"The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders","volume":"70","author":"Cullingford","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s42003-019-0455-x","article-title":"Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma","volume":"2","author":"Mukherjee","year":"2019","journal-title":"Commun. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat. Immunol."},{"key":"ref_33","first-page":"442","article-title":"Aging-related gene signature regulated by Nlrp3 predicts glioma progression","volume":"5","author":"Li","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lussier, D.M., Woolf, E.C., Johnson, J.L., Brooks, K.S., Blattman, J.N., and Scheck, A.C. (2016). Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2337-7"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1007\/s11064-019-02795-4","article-title":"Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?","volume":"44","author":"Seyfried","year":"2019","journal-title":"Neurochem. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3389\/fnut.2018.00020","article-title":"Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up","volume":"5","author":"Elsakka","year":"2018","journal-title":"Front. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3390\/cancers3010994","article-title":"Role of p53 in cell death and human cancers","volume":"3","author":"Ozaki","year":"2011","journal-title":"Cancers"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jmb.2017.03.030","article-title":"Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy","volume":"429","author":"Yue","year":"2017","journal-title":"J. Mol. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41419-019-1463-y","article-title":"P53 \u0392-Hydroxybutyrylation Attenuates P53 Activity","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/cimb43020042","article-title":"Ketogenic diet in cancer prevention and therapy: Molecular targets and therapeutic opportuities","volume":"43","author":"Talib","year":"2021","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.18632\/oncotarget.3629","article-title":"Targeting AMPK for cancer prevention and treatment","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1158\/1538-7445.AM10-638","article-title":"Mechanistic studies of the ketogenic diet as an adjuvant therapy for malignant gliomas","volume":"70","author":"Scheck","year":"2010","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/nop\/npv010","article-title":"Glycemic modulation in neuro-oncology: Experience and future directions using a modified Atkins diet for high-grade brain tumors","volume":"2","author":"Strowd","year":"2015","journal-title":"Neuro-Oncol. Pract."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41586-018-0343-4","article-title":"Suppression of insulin feedback enhances the efficacy of PI3K inhibitors","volume":"560","author":"Hopkins","year":"2018","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e108389","DOI":"10.15252\/embj.2021108389","article-title":"Cancer evolution: Darwin and beyond","volume":"40","author":"Vendramin","year":"2021","journal-title":"EMBO J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mco2.55","article-title":"Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment","volume":"2","author":"Liu","year":"2021","journal-title":"MedComm"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Alfarouk, K.O., Ahmed, S.B.M., Elliott, R.L., Benoit, A., Alqahtani, S.S., Ibrahim, M.E., Bashir, A.H.H., AlHoufie, S.T.S., Elhassan, G.O., and Wales, C.C. (2020). The pentose phosphate pathway dynamics in cancer and its dependency on intracellular pH. Metabolites, 10.","DOI":"10.3390\/metabo10070285"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-2867-9-14","article-title":"Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2","volume":"9","author":"Fine","year":"2009","journal-title":"Cancer Cell Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10555-014-9495-3","article-title":"Calories, carbohydrates, and cancer therapy with radiation: Exploiting the five R\u2019s through dietary manipulation","volume":"33","author":"Klement","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/WCO.0000000000000432","article-title":"New insights into the mechanisms of the ketogenic diet","volume":"30","author":"Boison","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1743-7075-7-74","article-title":"The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma","volume":"7","author":"Stafford","year":"2010","journal-title":"Nutr. Metab."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/cam4.775","article-title":"MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics","volume":"5","author":"Shea","year":"2016","journal-title":"Cancer Med."},{"key":"ref_54","first-page":"131","article-title":"A systematic review of MicroRNA in glioblastoma multiforme: Micro-modulators in the mesenchymal mode of migration and invasion","volume":"47","author":"Rasmussen","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"i28","DOI":"10.1093\/neuonc\/now292.015","article-title":"The ketogenic diet induces epigenetic changes that play key roles in tumour development","volume":"19","author":"Preston","year":"2017","journal-title":"Neuro-Oncology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"iv8","DOI":"10.1093\/neuonc\/noz167.033","article-title":"The ketogenic diet alters the epigenetic landscape of gbm to potentiate the effects of chemotherapy and radiotherapy","volume":"21","author":"Zeng","year":"2019","journal-title":"Neuro-Oncology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/sj.bjc.6601269","article-title":"Role of glucose and ketone bodies in the metabolic control of experimental brain cancer","volume":"89","author":"Seyfried","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Lv, M., Zhu, X., Wang, H., Wang, F., and Guan, W. (2014). Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: A systematic review and meta-analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0115147"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Maurer, G.D., Brucker, D.P., B\u00e4hr, O., Harter, P.N., Hattingen, E., Walenta, S., Mueller-Klieser, W., Steinbach, J.P., and Rieger, J. (2011). Differential utilization of ketone bodies by neurons and glioma cell lines: A rationale for ketogenic diet as experimental glioma therapy. BMC Cancer, 11.","DOI":"10.1186\/1471-2407-11-315"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3892\/ijo.2014.2382","article-title":"ERGO: A pilot study of ketogenic diet in recurrent glioblastoma","volume":"44","author":"Rieger","year":"2014","journal-title":"Int. J. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-7075-4-5","article-title":"The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer","volume":"4","author":"Zhou","year":"2007","journal-title":"Nutr. Metab."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Abdelwahab, M.G., Fenton, K.E., Preul, M.C., Rho, J.M., Lynch, A., Stafford, P., and Scheck, A.C. (2012). The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0036197"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Dang, M.T., Wehrli, S., Dang, C.V., and Curran, T. (2015). The ketogenic diet does not affect growth of Hedgehog pathway medulloblastoma in mice. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133633"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Morscher, R.J., Aminzadeh-Gohari, S., Feichtinger, R., Mayr, J.A., Lang, R., Neureiter, D., Sperl, W., and Kofler, B. (2015). Inhibition of neuroblastoma tumor growth by ketogenic diet and\/or calorie restriction in a CD1-nu mouse model. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0129802"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1080\/01635581.2020.1822423","article-title":"MR-Spectroscopy and Survival in Mice with High Grade Glioma Undergoing Unrestricted Ketogenic Diet","volume":"73","author":"Ciusani","year":"2020","journal-title":"Nutr. Cancer"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/neuonc\/now088","article-title":"A ketogenic diet increases transport and oxidation of ketone bodies in RG2 and 9L gliomas without affecting tumor growth","volume":"18","author":"Behar","year":"2016","journal-title":"Neuro-Oncology"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Klement, R.J., Champ, C.E., Otto, C., and K\u00e4mmerer, U. (2016). Anti-tumor effects of ketogenic diets in mice: A meta-analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0155050"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Javier, R., Wang, W., Drumm, M., McCortney, K., Sarkaria, J.N., and Horbinski, C. (2022). The efficacy of an unrestricted cycling ketogenic diet in preclinical models of IDH wild-type and IDH mutant glioma. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0257725"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11060-014-1362-0","article-title":"Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme","volume":"117","author":"Champ","year":"2014","journal-title":"J. Neurooncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3389\/fnins.2020.00390","article-title":"Exploring the Feasibility and Effects of a Ketogenic Diet in Patients With CNS Malignancies: A Retrospective Case Series","volume":"14","author":"Panhans","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11060-020-03417-8","article-title":"Ketogenic diets as an adjuvant therapy for glioblastoma (KEATING): A randomized, mixed methods, feasibility study","volume":"147","author":"Marson","year":"2020","journal-title":"J. Neurooncol."},{"key":"ref_72","first-page":"1758835919853958","article-title":"Ketogenic diet treatment as adjuvant to standard treatment of glioblastoma multiforme: A feasibility and safety study","volume":"11","author":"Olieman","year":"2019","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_73","first-page":"e2756","article-title":"Ketogenic diet treatment in recurrent diffuse intrinsic pontine glioma in children: A safety and feasibility study","volume":"66","author":"Reddingius","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e1383","DOI":"10.1002\/cnr2.1383","article-title":"Ketogenic diet treatment in diffuse intrinsic pontine glioma in children: Retrospective analysis of feasibility, safety, and survival data","volume":"4","author":"Perez","year":"2021","journal-title":"Cancer Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1194\/jlr.R046797","article-title":"The ketogenic diet for the treatment of malignant glioma","volume":"56","author":"EWoolf","year":"2015","journal-title":"J. Lipid Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11060-016-2364-x","article-title":"Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors: 1H-MRS study","volume":"132","author":"Artzi","year":"2017","journal-title":"J. Neurooncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/01635581.2018.1460677","article-title":"The Modified Ketogenic Diet in Adults with Glioblastoma: An Evaluation of Feasibility and Deliverability within the National Health Service","volume":"70","author":"Marson","year":"2018","journal-title":"Nutr. Cancer"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40170-020-00230-9","article-title":"Treatment of glioblastoma multiforme with \u2018classic\u2019 4:1 ketogenic diet total meal replacement","volume":"8","author":"Klein","year":"2020","journal-title":"Cancer Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11060-021-03786-8","article-title":"A Phase I clinical trial of dose-escalated metabolic therapy combined with concomitant radiation therapy in high-grade glioma","volume":"153","author":"Porper","year":"2021","journal-title":"J. Neurooncol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1002\/cam4.2362","article-title":"Clinical practice guidelines for the diagnosis and treatment of adult diffuse glioma-related epilepsy","volume":"8","author":"Liang","year":"2019","journal-title":"Cancer Med."},{"key":"ref_81","first-page":"1","article-title":"Ketogenic diets for drug-resistant epilepsy","volume":"6","author":"Bresnahan","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1570159X15666170517153509","article-title":"The Anticonvulsant Effects of Ketogenic Diet on Epileptic Seizures and Potential Mechanisms","volume":"16","author":"Zhang","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"U\u0142amek-Kozio\u0142, M., Czuczwar, S.J., Januszewski, S., and Pluta, R. (2019). Ketogenic Diet and Epilepsy. Nutirents, 11.","DOI":"10.3390\/nu11102510"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/07315724.1995.10718495","article-title":"Effects of a Ketogenic Diet on Tumor Metabolism and Nutritional Status in Pediatrie Oncology Patients: Two Case Reports","volume":"14","author":"Nebeling","year":"1995","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_85","first-page":"1","article-title":"Ketogenic diets for drug-resistant epilepsy (Review)","volume":"11","author":"Bresnahan","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1016\/j.clnu.2021.01.023","article-title":"A ketogenic diet consumed during radiotherapy improves several aspects of quality of life and metabolic health in women with breast cancer","volume":"40","author":"Klement","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.4161\/cc.9.17.12731","article-title":"Ketones and lactate \u2018fuel\u2019 tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism","volume":"9","author":"Bonuccelli","year":"2010","journal-title":"Cell Cycle"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e13053","DOI":"10.1111\/obr.13053","article-title":"Scientific evidence underlying contraindications to the ketogenic diet: An update","volume":"21","author":"Watanabe","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"21807","DOI":"10.1038\/srep21807","article-title":"Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis","volume":"6","author":"Liskiewicz","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.cmet.2016.12.010","article-title":"Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor Growth","volume":"25","author":"Xia","year":"2017","journal-title":"Cell Metab."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/18\/3851\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:33:32Z","timestamp":1760142812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/14\/18\/3851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,17]]},"references-count":90,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["nu14183851"],"URL":"https:\/\/doi.org\/10.3390\/nu14183851","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,17]]}}}